Connor, Clark & Lunn Investment Management (CC&L)’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$237K Buy
2024
Q2
Sell
2024
Q1
$1.61M Buy